Scientific paper - Review paper
Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
Reumatologia/Rheumatology, 58 (2020), 6; 390-400. https://doi.org/10.5114/reum.2020.101400

Padjen, Ivan; Reihl Crnogaj, Mirna; Anić, Branimir

Cite this document

Padjen, I., Reihl Crnogaj, M. & Anić, B. (2020). Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms. Reumatologia/Rheumatology, 58. (6), 390-400. doi: 10.5114/reum.2020.101400

Padjen, Ivan, et al. "Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms." Reumatologia/Rheumatology, vol. 58, no. 6, 2020, pp. 390-400. https://doi.org/10.5114/reum.2020.101400

Padjen, Ivan, Mirna Reihl Crnogaj and Branimir Anić. "Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms." Reumatologia/Rheumatology 58, no. 6 (2020): 390-400. https://doi.org/10.5114/reum.2020.101400

Padjen, I., Reihl Crnogaj, M. and Anić, B. (2020) 'Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms', Reumatologia/Rheumatology, 58(6), pp. 390-400. doi: 10.5114/reum.2020.101400

Padjen I, Reihl Crnogaj M, Anić B. Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms. Reumatologia/Rheumatology [Internet]. 2020 [cited 2024 February 17];58(6):390-400. doi: 10.5114/reum.2020.101400

I. Padjen, M. Reihl Crnogaj and B. Anić, "Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms", Reumatologia/Rheumatology, vol. 58, no. 6, pp. 390-400, 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:515748. [Accessed: 17 February 2024]

Please login to the repository to save this object to your list.